Trial Profile
Interventions study for the control of diabetes mellitus type 2 in obese women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 27 Aug 2007 Status changed from recruiting to completed.
- 27 Mar 2006 New trial record.